AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26
EFFICACY AND ADVERSE EVENTS OF SUBCUTANEOUS, ORAL, AND INTRANASAL SUMATRIPTAN USED FOR MIGRAINE TREATMENT - A SYSTEMATIC REVIEW BASED ON NUMBER NEEDED TO TREAT
Authors: TFELTHANSEN P
Citation: P. Tfelthansen, EFFICACY AND ADVERSE EVENTS OF SUBCUTANEOUS, ORAL, AND INTRANASAL SUMATRIPTAN USED FOR MIGRAINE TREATMENT - A SYSTEMATIC REVIEW BASED ON NUMBER NEEDED TO TREAT, Cephalalgia, 18(8), 1998, pp. 532-538
ETHICAL ISSUES IN HEADACHE RESEARCH AND MANAGEMENT - REPORT AND RECOMMENDATIONS OF THE ETHICS SUBCOMMITTEE OF THE INTERNATIONAL-HEADACHE-SOCIETY
Authors: STEINER TJ DANDREA G GABBAY FJ HARPWOOD VM ISLER H LLOYD KM MERIKANGAS KR PEREIRAMONTEIRO JM PRIBAN J REEVES KR ROTHNER D RUSSELL D SOLOMON S TFELTHANSEN P
Citation: Tj. Steiner et al., ETHICAL ISSUES IN HEADACHE RESEARCH AND MANAGEMENT - REPORT AND RECOMMENDATIONS OF THE ETHICS SUBCOMMITTEE OF THE INTERNATIONAL-HEADACHE-SOCIETY, Cephalalgia, 18(7), 1998, pp. 505-529
GUIDELINES FOR THE MANAGEMENT OF HEADACHE
Authors: JENSEN K ANKJAERJENSEN A HANSEN PE HOLMTHOMSEN OE KORSGAARD AG KRABBE AA NIELSEN MR OLESEN J TFELTHANSEN P
Citation: K. Jensen et al., GUIDELINES FOR THE MANAGEMENT OF HEADACHE, Cephalalgia, 18(1), 1998, pp. 9-22
THE LONG-TERM TOLERABILITY AND EFFICACY OF ORAL ZOLMITRIPTAN (ZOMIG, 311C90) IN THE ACUTE TREATMENT OF MIGRAINE - AN INTERNATIONAL STUDY
Authors: ADELMAN JU BAUMEL B CADY RK BAKER CC COUCH JR DALESSIO DJ DIAMOND S ELKIND AH FOSTER CA GOLDSTEIN J KATZ DA KIRCHNER JR KLAPPER JA KUDROW DB KUNKEL R LANDY SH LICHT JM LINDER SL LODER E MARKLEY HG MATHEW NT MEYER JS NETT R PACKARD RC PERSE T PETERS KS RAMADAN NM RAPOPORT AM ROSING HS SADOWSKY C SAPER JR SHARFMAN MI SILBERSTEIN SD SINGER RP SMITH R SOLOMON G SOLOMON S STARK SR SWANSON JW TAYLOR FR TEPPER SJ TUCHMAN MM VIJAYAN N WALKER J WARD T WARNER JS WENDT JK WINNER P BERAN P BLACK A DONNAN G HERKES G LORD G ZAGAMI A BAUMHACKL U BROUSSALIS T KLINGLER D LADURNER G JACQUY J LOUIS P SCHOENEN J GAWEL MJ HANSEN PE JENSEN K PEDERSEN KK KORSGAARD A LADEMANN A OLESEN J SIMONSEN N SORENSEN PS JENSEN TS TFELTHANSEN P KAASIK AE ZUPPING R FARKKILA M HAANPAA M HAVANKA H HEDMAN C ILMAVIRTA M KINNUNEN E LIUKKONEN J PARTINEN M RAUTAKORPI I REUNANEN M SAKO E SEPPA JM BAREGE M CHAZOT G COLOMBANI JP DUJARDIN M FABRE N GIACOMINO A GERAUD G HENRY P",JOGEIX,"LAPORTE A",LICHTBLAU,"MASSIOU H",MAZINGUEDESAILLY,"MIHOUT B PETIT H VEYRIE M VILAREM H WILMANN JF BECKMANNREINHOLDT A DIENER HC EVERS S GOBEL H KLEPEL H KUHL W LANGOHR HD NEU I PAULUS W PEIKERT A PFAFFENRATH V SCHOLZ E STRAUBE A WITTE OW HARMOUSI S KARAGEORGIOU C MILONAS I GIACOVAZZO M NAPPI G TERBERG JWM SANDERS EACM VANDERZWAN JL EDLAND A ENGELSEN B GRONNING M HALDORSEN T HODNEBO A LARSEN JP DORNZAL T PRUSINSKI A SZCZUDLIK A NAYA MG GRANELL AN LAINEZ JM LEIRA R LIANO H PASCUAL J BOIVIE J DAHLOF C EDVINSSON L HARDEBO JE NILSSON H WALDENLIND E ISLER HR CRAWFORD P DOWSON AJ FINDLEY L GROSS M HAWKES CH JESTICO J ROLAN P STEINER TJ WILKINSON M WAGNER G
Citation: Ju. Adelman et al., THE LONG-TERM TOLERABILITY AND EFFICACY OF ORAL ZOLMITRIPTAN (ZOMIG, 311C90) IN THE ACUTE TREATMENT OF MIGRAINE - AN INTERNATIONAL STUDY, Headache, 38(3), 1998, pp. 173-183
PROPHYLACTIC PHARMACOTHERAPY OF MIGRAINE - SOME PRACTICAL GUIDELINES
Authors: TFELTHANSEN P
Citation: P. Tfelthansen, PROPHYLACTIC PHARMACOTHERAPY OF MIGRAINE - SOME PRACTICAL GUIDELINES, Neurologic clinics, 15(1), 1997, pp. 153
HOW TO DEFINE THE BEST EFFICACY PARAMETERS FOR MIGRAINE
Authors: TFELTHANSEN P
Citation: P. Tfelthansen, HOW TO DEFINE THE BEST EFFICACY PARAMETERS FOR MIGRAINE, Cephalalgia, 17, 1997, pp. 6-8
HOW TO DEFINE THE BEST EFFICACY PARAMETERS FOR MIGRAINE - DISCUSSION
Authors: MASSIOU H TFELTHANSEN P GOADSBY P FERRARI M EDMEADS J DAHLOF C SCHOENEN J
Citation: H. Massiou et al., HOW TO DEFINE THE BEST EFFICACY PARAMETERS FOR MIGRAINE - DISCUSSION, Cephalalgia, 17, 1997, pp. 8-9
MEASURING CENTRAL ACTION OF ACUTE ANTIMIGRAINE DRUGS IN HUMANS - DISCUSSION
Authors: TFELTHANSEN P SCHOENEN J EDMEADS J DAHLOF C FERRARI M GOADSBY P
Citation: P. Tfelthansen et al., MEASURING CENTRAL ACTION OF ACUTE ANTIMIGRAINE DRUGS IN HUMANS - DISCUSSION, Cephalalgia, 17, 1997, pp. 15-16
WOULD ANY ACUTE TREATMENT FOR MIGRAINE DEMONSTRATE RECURRENCE - DISCUSSION
Authors: TFELTHANSEN P FERRARI M GOADSBY P DAHLOF C MASSIOU H
Citation: P. Tfelthansen et al., WOULD ANY ACUTE TREATMENT FOR MIGRAINE DEMONSTRATE RECURRENCE - DISCUSSION, Cephalalgia, 17, 1997, pp. 19-20
WHAT IS LACKING IN THE TREATMENT OF PEDIATRIC AND ADOLESCENT MIGRAINE- DISCUSSION
Authors: TFELTHANSEN P MASSIOU H GOADSBY P FERRARI M SCHOENEN J EDMEADS J
Citation: P. Tfelthansen et al., WHAT IS LACKING IN THE TREATMENT OF PEDIATRIC AND ADOLESCENT MIGRAINE- DISCUSSION, Cephalalgia, 17, 1997, pp. 23-24
WHAT IS THE ROLE OF INTERNATIONAL SOCIETIES AND WHAT COULD THEY DO BETTER - DISCUSSION
Authors: EDMEADS J ANTONACI F GOADSBY P FERRARI M DAHLOF C TFELTHANSEN P
Citation: J. Edmeads et al., WHAT IS THE ROLE OF INTERNATIONAL SOCIETIES AND WHAT COULD THEY DO BETTER - DISCUSSION, Cephalalgia, 17, 1997, pp. 27-28
SUMATRIPTAN HAS NO CLINICALLY RELEVANT EFFECT IN THE TREATMENT OF EPISODIC TENSION-TYPE HEADACHE
Authors: BRENNUM J BRINCK T SCHRIVER L WANSCHER B SORENSEN PS TFELTHANSEN P OLESEN J
Citation: J. Brennum et al., SUMATRIPTAN HAS NO CLINICALLY RELEVANT EFFECT IN THE TREATMENT OF EPISODIC TENSION-TYPE HEADACHE, European journal of neurology, 3(1), 1996, pp. 23-28
DRUG-TREATMENT OF MIGRAINE - ACUTE TREATMENT AND MIGRAINE PROPHYLAXIS
Authors: TFELTHANSEN P
Citation: P. Tfelthansen, DRUG-TREATMENT OF MIGRAINE - ACUTE TREATMENT AND MIGRAINE PROPHYLAXIS, Current opinion in neurology, 9(3), 1996, pp. 211-213
ORAL SUMATRIPTAN
Authors: TFELTHANSEN P
Citation: P. Tfelthansen, ORAL SUMATRIPTAN, Neurology, 47(2), 1996, pp. 612-612
GUIDELINES FOR CONTROLLED TRIALS OF DRUGS IN CLUSTER HEADACHE
Authors: LIPTON RB MICIELI G RUSSELL D SOLOMON S TFELTHANSEN P WALDENLIND E
Citation: Rb. Lipton et al., GUIDELINES FOR CONTROLLED TRIALS OF DRUGS IN CLUSTER HEADACHE, Cephalalgia, 15(6), 1995, pp. 452-462
INTRODUCTION OF A NOVEL SELF-INJECTOR FOR SUMATRIPTAN - A CONTROLLED CLINICAL-TRIAL IN GENERAL-PRACTICE
Authors: JENSEN K TFELTHANSEN P HANSEN EW KROIS EH PEDERSEN OS
Citation: K. Jensen et al., INTRODUCTION OF A NOVEL SELF-INJECTOR FOR SUMATRIPTAN - A CONTROLLED CLINICAL-TRIAL IN GENERAL-PRACTICE, Cephalalgia, 15(5), 1995, pp. 423-429
PROPHYLACTIC TREATMENT OF MIGRAINE - EVALUATION OF CLINICAL-TRIALS AND CHOICE AMONG DRUGS
Authors: TFELTHANSEN P
Citation: P. Tfelthansen, PROPHYLACTIC TREATMENT OF MIGRAINE - EVALUATION OF CLINICAL-TRIALS AND CHOICE AMONG DRUGS, Cephalalgia, 15, 1995, pp. 29-32
THE EFFECTIVENESS OF COMBINED ORAL LYSINE ACETYLSALICYLATE AND METOCLOPRAMIDE COMPARED WITH ORAL SUMATRIPTAN FOR MIGRAINE
Authors: TFELTHANSEN P HENRY P MULDER LJ SCHELDEWAERT RG SCHOENEN E CHAZOT G
Citation: P. Tfelthansen et al., THE EFFECTIVENESS OF COMBINED ORAL LYSINE ACETYLSALICYLATE AND METOCLOPRAMIDE COMPARED WITH ORAL SUMATRIPTAN FOR MIGRAINE, Lancet, 346(8980), 1995, pp. 923-926
MIGRAINE - DIAGNOSIS AND PATHOPHYSIOLOGY
Authors: TFELTHANSEN P
Citation: P. Tfelthansen, MIGRAINE - DIAGNOSIS AND PATHOPHYSIOLOGY, Pharmacology & toxicology, 75, 1994, pp. 72-75
ABNORMAL INHOMOGENEOUS RCBF PATTERNS IN MIGRAINE PATIENTS EXAMINED WITH SPECT BETWEEN ATTACKS
Authors: FRIBERG L OLESEN J IVERSEN HK NICOLIC I SPERLING B LASSEN NA OLSEN TS TFELTHANSEN P
Citation: L. Friberg et al., ABNORMAL INHOMOGENEOUS RCBF PATTERNS IN MIGRAINE PATIENTS EXAMINED WITH SPECT BETWEEN ATTACKS, Stroke, 25(3), 1994, pp. 750-750
NO EFFECT OF THE 5HT(2)-ANTAGONIST ICI-169,369 ON SYSTOLIC, ERGOTAMINE-INDUCED BLOOD-PRESSURE CHANGES IN MAN
Authors: NIELSEN TH TFELTHANSEN P
Citation: Th. Nielsen et P. Tfelthansen, NO EFFECT OF THE 5HT(2)-ANTAGONIST ICI-169,369 ON SYSTOLIC, ERGOTAMINE-INDUCED BLOOD-PRESSURE CHANGES IN MAN, Pharmacology & toxicology, 73(3), 1993, pp. 133-136
SUMATRIPTAN FOR THE TREATMENT OF MIGRAINE ATTACKS - A REVIEW OF CONTROLLED CLINICAL-TRIALS
Authors: TFELTHANSEN P
Citation: P. Tfelthansen, SUMATRIPTAN FOR THE TREATMENT OF MIGRAINE ATTACKS - A REVIEW OF CONTROLLED CLINICAL-TRIALS, Cephalalgia, 13(4), 1993, pp. 238-244
SMALL ARTERIES CAN BE ACCURATELY STUDIED IN-VIVO, USING HIGH-FREQUENCY ULTRASOUND
Authors: NIELSEN TH IVERSEN HK TFELTHANSEN P OLESEN J
Citation: Th. Nielsen et al., SMALL ARTERIES CAN BE ACCURATELY STUDIED IN-VIVO, USING HIGH-FREQUENCY ULTRASOUND, Ultrasound in medicine & biology, 19(9), 1993, pp. 717-725
ASSOCIATION BETWEEN SUMATRIPTAN AND STROKE
Authors: TFELTHANSEN P FERRARI MD OLESEN J
Citation: P. Tfelthansen et al., ASSOCIATION BETWEEN SUMATRIPTAN AND STROKE, Lancet, 342(8866), 1993, pp. 303-303
REDUCED CONTRALATERAL HEMISPHERIC FLOW MEASURED BY SPECT IN CEREBELLAR LESIONS - CROSSED CEREBRAL DIASCHISIS
Authors: SONMEZOGLU K SPERLING B HENRIKSEN T TFELTHANSEN P LASSEN NA
Citation: K. Sonmezoglu et al., REDUCED CONTRALATERAL HEMISPHERIC FLOW MEASURED BY SPECT IN CEREBELLAR LESIONS - CROSSED CEREBRAL DIASCHISIS, Acta neurologica Scandinavica, 87(4), 1993, pp. 275-280
Risultati: 1-25 | 26-26